All Columns articles – Page 13
-
OpinionAlzheimer’s, amyloid and abandoned antibodies
Biogen’s aducanumab is stumbling into obscurity. Where does that leave the amyloid hypothesis?
-
OpinionEnergy is the Achilles’ heel of carbon capture technologies
Efforts to trap carbon dioxide could consume a huge amount of forecast renewable energy growth
-
OpinionCatalogues of complexity
The tangled web of fine chemicals supply frequently throws up surprises
-
OpinionReformed and refreshed
Chemistry comes out of the latest Research Excellence Framework exercise looking good
-
OpinionExit strategy
Overcoming a major setback showed Derek Lowe could make it through graduate school
-
OpinionA spanner in the works
Most drugs work by breaking or stopping something, rather than by making something faster or better
-
-
OpinionDiversifying in two dimensions
Artisanal assemblies are opening up pathways to exciting and exotic phenomena
-
-
OpinionScents and sentimentality
Deprived of familiar lab odours, Derek Lowe indulges in some nasal nostalgia
-
OpinionWhat next for the US’s China Initiative after the case against MIT’s Gang Chen falls apart?
The US’s probe into researchers’ ties to China and potential theft of intellectual property stands on a knife edge
-
OpinionThe law of conservation of data
AI and machine learning are useful and powerful, but they need high quality data inputs that aren’t available yet for drug discovery
-
-
-
OpinionWhen regulatory cooperation goes too far, we all lose
Were FDA staff unduly influenced by Biogen in approving Alzheimer’s antibody?
-
-
OpinionThe impact of shipping delays on chemical industries
Supply chain difficulties don’t only affect supermarkets
-
OpinionHooray for milk
We’re still uncovering the secrets of breast milk, but what we know so far is fascinating
-
OpinionReverse combustion is preparing for takeoff
Where burning hydrocarbons is unavoidable, creating them from atmospheric carbon is a promising option
-
